Navigation Links
Breast-Specific Gamma Imaging Proves Highly Sensitive for the Detection of Ductal Carcinoma In Situ
Date:11/30/2009

erform BSGI. With BSGI, the patient receives a pharmaceutical tracing agent that is absorbed by all the cells in the body. Due to their increased rate of metabolic activity, cancerous cells in the breast absorb a greater amount of the tracing agent than the normal surrounding tissue and generally appear as "hot spots" on the BSGI image.

About Dilon Diagnostics

Dilon Diagnostics, a brand of Dilon Technologies Inc., is bringing innovative medical imaging products to market. Dilon's cornerstone product, the Dilon 6800, is a high-resolution, compact gamma camera, optimized to perform BSGI, a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake. Many leading medical centers around the country are now offering BSGI to their patients, including: Cornell University Medical Center, New York; George Washington University Medical Center, Washington, D.C.; and The Rose, Houston. For more information on Dilon Diagnostics please visit www.dilon.com.

SOURCE Dilon Diagnostics


'/>"/>
SOURCE Dilon Diagnostics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy
2. Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI)
3. Breast-Specific Gamma Imaging Proves Cost-Effective for Pre-Surgical Planning of Patients with Known Cancer Diagnosis
4. Community Breast Center Experience Shows Real-World Application of Breast-Specific Gamma Imaging Has Significant Impact on Clinical Care
5. Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
6. Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion
7. Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex)
8. U.S. FDA Issues Action Letter for Sugammadex
9. BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
10. European Unions CHMP Issues Positive Opinion on Sugammadex
11. Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimers Disease Announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... HOUSTON , March 26, 2015  The ... of a study independently conducted by the Department ... Japan have been published. ... compared 5-fluorouracil hepatic arterial infusion as post-operative adjuvant ... colorectal metastasis of the liver. ...
(Date:3/26/2015)... , March 26, 2015 Huntington Memorial Hospital ... to perform transcatheter aortic valve replacement (TAVR), a minimally ... a revolutionary new way to replace an aortic valve ... heart lung machine. The procedure is performed ... by Azhil ( Alex) Durairaj , MD, interventional cardiologist ...
(Date:3/26/2015)... VANCOUVER, British Columbia, March 26, 2015  OncoGenex ... a summary of clinical developments and announced fourth ... Clinical Developments and Anticipated Near-term MilestonesCustirsen ... and Teva agreed to negotiate the termination of ... Negotiations of the final termination agreement are ongoing. ...
Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 2OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 3OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 4OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 5OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 6OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 7OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014 8
(Date:3/30/2015)... (PRWEB) March 30, 2015 Developing new ... to the use of cellular models that recapitulate only ... entirety of the disease. , A company that ... cells to precise specifications has created iPSC-derived cardiomyocytes ... environmentally and genetically driven in vitro models of Diabetes ...
(Date:3/29/2015)... SAN DIEGO, Calif. (PRWEB) March 30, 2015 ... suffering from menopause-related symptoms tied to undiagnosed autoimmune, thyroid, ... authority on thyroid disorders, has personally treated hundreds of ... of women are unaware of the treatment options for ... Your Mojo?” offers solutions to women living with fatigue, ...
(Date:3/29/2015)... Telerad RxDx Multispecialty Healthcare Center, Whitefield ... on 11th January 2015. The accreditation from NABH ... comes as a true recognition of the patient ... With Telerad RxDx being the first healthcare center ... a major achievement and a significant step towards ...
(Date:3/29/2015)... D.C. USA (PRWEB) March 29, 2015 ... Health Link platform provides basic health information ... the opportunity to discuss these challenges as well ... Afro Health Link addresses six medical conditions using ... encourage users to engage in conversations around them., ...
(Date:3/28/2015)... Rocket Pure , a manufacturer of natural ... their new natural sunscreen. They are offering the sunscreen ... options come with a bonus lip balm sunscreen. , The ... Click to see the natural sunscreen on Amazon ... is made with non-nano zinc oxide and provides broad-based protection ...
Breaking Medicine News(10 mins):Health News:Cellular Dynamics’ Webinar Spotlights Diabetic Cardiomyopathy-in-a-dish Model that May Elucidate Mechanisms for Repair and Regeneration of Heart Muscle Cells 2Health News:Cellular Dynamics’ Webinar Spotlights Diabetic Cardiomyopathy-in-a-dish Model that May Elucidate Mechanisms for Repair and Regeneration of Heart Muscle Cells 3Health News:Cellular Dynamics’ Webinar Spotlights Diabetic Cardiomyopathy-in-a-dish Model that May Elucidate Mechanisms for Repair and Regeneration of Heart Muscle Cells 4Health News:How to Turn Mid-life into the Good Life 2Health News:NABH Accreditation for Telerad RxDx – Whitefield. 2Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 2Health News:Krame Health Solutions Announces Release of AfroHealthLink, an Interactive Health Resource Center Tailored to Individuals of African & Caribbean Descent Around the World 3Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 2Health News:Rocket Pure Releases New Natural Sunscreens For Athletes 3
... leader in soft-cloth nasal CPAP masks, announces the new Zzzephyr ... comfortably over the patient,s nose. The lightweight seal reduces air ... Obstructive Sleep Apnea patients. , The SleepWeaver ADVANCE with Zzzephyr ... at the Medtrade Fall Show in Atlanta, Georgia, October 12 ...
... Calif., Oct. 26 Ingenuity Systems, the leading provider ... it has developed a new gene expression workflow with ... and the Applied Biosystems SOLiD(TM) System and TaqMan® Gene ... for researchers to analyze and understand the transcriptome of ...
... particularly younger women, experienced larger improvements in hospital mortality ... study published in the Oct. 26, 2009 issue of ... decade several studies showed that younger women, but not ... hospital after MI than age-matched men. A team of ...
... The topical application ... and absorption throughout the surface of the skin and scalp. A new line of naturally ... for a variety of topical conditions affecting the skin, scalp and feet. , ... Schenectady, NY (PRWEB) October 26, 2009 -- ...
... ... announce it has been honored with the BayCare Quality Award for the team,s project ... patient successes including follow through on outpatient office visits, 30-day readmission rates, and A1c ... ...
... Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) ... modification and Lorcaserin for Overweight and Obesity Management) ... weight loss, improved markers of cardiovascular risk and ... or suicidal ideation. Additional subgroup analyses showed that ...
Cached Medicine News:Health News:Circadiance Launches NEW Zzzephyr Seal(TM) for Its SleepWeaver(TM) ADVANCE Mask - Now Available in Three Colors 2Health News:Ingenuity Systems Enhances Workflow for Experimental Transcriptome Analysis in Single Cells 2Health News:Survival after heart attack improves in younger women 2Health News:Caffeinated Cayenne Pepper Body Sprays Relieve Common Skin and Scalp Problems 2Health News:Caffeinated Cayenne Pepper Body Sprays Relieve Common Skin and Scalp Problems 3Health News:IN Compass Health's Hospitalist Team at Morton Plant wins first BayCare Quality Award 2Health News:IN Compass Health's Hospitalist Team at Morton Plant wins first BayCare Quality Award 3Health News:Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation 2Health News:Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation 3Health News:Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation 4Health News:Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation 5Health News:Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation 6Health News:Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation 7Health News:Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation 8
Inquire...
... The Eppendorf Reference Series 2000 Pipette ... smooth stroke, a compact and robust design, ... button is used to operate the measuring ... the tip. Product features:Eppendorf "pipette/tip" system ensures ...
... The new Finnpipette Focus ... specifically to combine ergonomics with ... interchangeable handle plate offers a ... sizes. The new shorter tip ...
... A fixed pipette is ideal ... single volume. Fixed volume FInnpipettes ... advantages as other Finnpipette Digital ... Super blow-out (1-40ul), Soft-touch tip ...
Medicine Products: